Nuclear Imaging

  • Positron emission tomography (PET) is used commonly in the diagnosis of suspected lung cancer. Computed bioconductance (CB) id being investigated as a non-invasive way to predict whether an suspicious abnormality in the lung is benign or malignant. In a new study, researchers found that CB combined...
  • IBA (Ion Beam Applications S.A.) announced the sale of IBA Molecular (IBAM) in which IBA had a 40 percent stake, to funds advised by CapVest Partners LP (“CapVest”), has closed successfully.
  • New research shows that innovative scanning-led surveillance can help identify the need for, and guidance of, neck dissection for head and neck cancer patients. This discovery means patients may no longer have to undergo invasive post-treatment surgery to remove remaining cancer cells.
  • Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Biograph Horizon positron emission tomography/computed tomography (PET/CT) system, which offers premium performance at a low total cost of ownership.
  • In October, Siemens Healthcare debuted a host of imaging systems that enable RT professionals to go further in the direction of personalized therapy.
China, computed bioconductance, CB, PET, positron emission tomography, lung lesions
News | PET Imaging | May 25, 2016
Positron emission tomography (PET) is used commonly in the diagnosis of suspected lung cancer. Computed bioconductance...
Technology | Imaging | May 18, 2016
May 18, 2016 — The Intersocietal Accreditation Commission (IAC) recently announced its launch of the IAC QI Self-Asse
enterprise imaging

Sea Lamprey photo courtesy of U.S. Fish and Wildlife Service

Blog | Enterprise Imaging | May 18, 2016
Physicians work differently. What they do and how they do it depends on their specialty. Radiologists and cardiologists...
Blue Earth Diagnostics, U.S. headquarters, management expansion, PET imaging agent
News | Radiopharmaceuticals and Tracers | May 13, 2016
Blue Earth Diagnostics, a molecular imaging diagnostics company, announced it has established operations in the United...
News | Radiopharmaceuticals and Tracers | May 13, 2016
NorthStar Medical Radioisotopes LLC is enhancing its production operations at the University of Missouri Research...
tau protein, Alzheimer's, PET scan, imaging agent, brain decline, Washington University in St. Louis

A study using a new PET imaging agent shows that measures of tau protein in the brain more closely track cognitive decline due to Alzheimer's disease compared with long-studied measures of amyloid beta. More red color indicates more tau protein. The image on the left shows the average tau accumulation in the brains of cognitively normal people, averaged over many individuals. The image on the right shows the average amount of tau buildup in the brains of multiple people with mild Alzheimer's symptoms. Scanning multiple individuals shows that the intensity of tau deposits correlates with the severity of cognitive dysfunction. Image courtesy of Matthew R. Brier.

News | PET Imaging | May 12, 2016
Using a new imaging agent that binds to tau protein and makes it visible in positron emission tomography (PET) scans,...
News | Radiopharmaceuticals and Tracers | May 11, 2016
May 11, 2016 — ITM (Isotopen Technologien München AG), a specialized radiopharmaceutical company, announced that the
Medraysintell, SNMMI 2016, nuclear imaging reports
News | Nuclear Imaging | May 10, 2016
May 10, 2016 — MEDraysintell announced it will display its series of market reports and directories during the Societ
cardiac magnetic resonance, CMR, SPECT, major adverse cardiovascular events, MACE predictor, Annals of Internal Medicine study
News | Cardiac Imaging | May 10, 2016
Cardiovascular magnetic resonance (CMR) is a stronger predictor of risk for major adverse cardiovascular events (MACE)...
Gamma Medica, Be Certain education campaign, breast density, microsite, molecular breast imaging
News | Breast Density | May 09, 2016
Gamma Medica, provider of molecular breast imaging technology (MBI), announced it has launched the Be Certain campaign...
News | Radiopharmaceuticals and Tracers | May 09, 2016
A recent study demonstrates that Ga-68 DOTATATE positron emission tomography (PET)/computed tomography (CT) scans are...
Carestream, oncology workflow, PET/CT, Vue Motion
Technology | Oncology Diagnostics | May 05, 2016
Carestream now offers an oncology reading workflow for positron emission tomography (PET)/computed tomography (CT)...
GE Healthcare, general purpose digital SPECT/CT, Discovery NM/CT 670 CZT, Barnes-Jewish Hospital, first U.S. install
News | SPECT-CT | May 05, 2016
Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose...

Early detection of cancer lesions with the latest generation of PET/CT scanners supports improved patient management. Yet much of PET’s potential, particularly for following patients and as a component in PET/MR, remains unrealized. (Image courtesy of Siemens Healthcare and the University of Tennessee, Knoxville)

Feature | Imaging | April 29, 2016 | Greg Freiherr
Adopting medical technology because it is new or novel lost its luster a long time ago. It is little wonder then that...

Photo courtesy of GE Healthcare

Feature | Imaging | April 29, 2016 | Jeff Zagoudis
The last 12 months have seen significant growth in the positron emission tomography/computed tomography (PET/CT)...

PET/MR images courtesy of GE Healthcare

Blog | Molecular Imaging | April 27, 2016
In the world of molecular imaging, PET/MR is a wild card. But it’s a wild card that’s ready to be played. Three major...
UltraSPECT, 10th anniversary, WBR technology, Wide Beam Reconstruction, FDA approval, nuclear imaging
News | Nuclear Imaging | April 21, 2016
UltraSPECT Inc. announced the 10th anniversary of the U.S. Food and Drug Administration (FDA) approval of its Wide Beam...
Mirada Medical, The Christie Hospital, England, PET-MRI, radiation therapy
News | Nuclear Imaging | April 20, 2016
Mirada Medical announced a new agreement to work with the clinicians and physicists at The Christie Hospital in...

Photo courtesy of Pixabay

Blog | Molecular Imaging | April 20, 2016
It’s been a long time since radiology focused just on the detection of disease. And it will never see those days again.

Graphic courtesy Pixabay

Blog | Molecular Imaging | April 13, 2016
The intersection between PET/CT and radiation therapy is widening. And it is doing so in unanticipated ways.
Overlay Init